瘤突变负担作为转移性传播模式的决定因素
Eduardo Candeal1, Andrea Moreno-Manuel1, Miguel Salvadó-Pertierra1
1Cancer Heterogeneity and Immunomics (CHI), Clinical University Hospital Lozano Blesa, Aragon Health Research Institute (IISA), Zaragoza, Spain.
Molecular oncology
|January 27, 2026
概括
瘤突变负担 (TMB) 趋势,而不是驱动突变,影响癌症扩散的地方. 大脑和肺转移中较高的TMB与更好的结果相关,可能指导免疫治疗策略.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 癌症转移研究 癌症转移研究
背景情况:
- 种子和土壤假设假设转移器官的特异性受到瘤和微环境因素的影响.
- 了解转移性传播的基因组基础对于向治疗至关重要.
研究的目的:
- 研究突变格局在确定各种癌症类型中转移性传播模式中的作用.
- 探索特定突变趋势和转移性有机化之间的关联.
主要方法:
- 分析了来自9种癌症类型 (膀,乳腺,结直肠,子宫内膜,黑色素瘤,非小细胞肺癌,卵巢,胰腺和前列腺) 的19827名患者的基因组数据.
- 对驱动突变和瘤总突变负荷 (TMB) 与转移位置相关的检查.
- 使用免疫疗法治疗患者的独立数据集验证发现.
主要成果:
- 在所有癌症类型中都没有发现与转移部位相关的一致驱动突变模式.
- 当单独分析癌症类型时,与特定的转移位置相关的明显突变趋势出现了.
- 与其他部位相比,中枢神经系统 (中枢神经系统) /大脑和肺部转移表现出更高的TMB.
- 中枢神经系统/大脑转移的更高TMB与改善的预后有关,在接受免疫治疗的患者中得到证实.
结论:
- 总瘤突变负担 (TMB) 在转移性有机化中似乎比驱动突变发挥更重要的作用.
- 研究结果表明TMB是改进免疫疗法策略的潜在生物标志物,特别是在中枢神经系统/大脑和肺转移方面.
关键词:
TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB免疫疗法 免疫疗法转移 转移 转移 转移突变是发生在突变中的突变.器官形主义 器官形主义预后生物标志物 预后生物标志物更多相关视频
09:14An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
Published on: August 11, 2011
16.3K
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
11.6K
相关概念视频
Mutations
94.4K
Overview
94.4K
Mutations
44.4K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.4K
Viral Mutations
39.8K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.8K
Mutation, Gene Flow, and Genetic Drift
63.8K
In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
63.8K
Mutations in Microorganisms
715
Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
715
Point and Frameshift Mutations
1.1K
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
1.1K
